Parents
Sign in to add mentor| W. Mark Saltzman | grad student | 2009 | Yale | |
| (Engineering drug delivery into regenerative medicine: Enhancing therapeutic vascularization through a combined molecular and cellular approach.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Born LJ, Chang KH, Shoureshi P, et al. (2021) HOTAIR-Loaded Mesenchymal Stem/Stromal Cell Extracellular Vesicles Enhance Angiogenesis and Wound Healing. Advanced Healthcare Materials. e2002070 |
| Piard C, Jeyaram A, Liu Y, et al. (2019) 3D printed HUVECs/MSCs cocultures impact cellular interactions and angiogenesis depending on cell-cell distance. Biomaterials. 222: 119423 |
| Pottash AE, Kuffner C, Noonan-Shueh M, et al. (2019) Protein-based vehicles for biomimetic RNAi delivery. Journal of Biological Engineering. 13: 19 |
| Patel DB, Luthers CR, Lerman MJ, et al. (2018) Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system. Acta Biomaterialia |
| Lamichhane TN, Jay SM. (2018) Production of Extracellular Vesicles Loaded with Therapeutic Cargo. Methods in Molecular Biology (Clifton, N.J.). 1831: 37-47 |
| Jeyaram A, Jay SM. (2017) Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications. The Aaps Journal. 20: 1 |
| Lamichhane TN, Leung CA, Douti LY, et al. (2017) Ethanol Induces Enhanced Vascularization Bioactivity of Endothelial Cell-Derived Extracellular Vesicles via Regulation of MicroRNAs and Long Non-Coding RNAs. Scientific Reports. 7: 13794 |
| Adams KR, Chauhan S, Patel DB, et al. (2017) Ubiquitin conjugation probed by inflammation in MDSC extracellular vesicles. Journal of Proteome Research |
| Jay SM, Vunjak-Novakovic G. (2017) Extracellular Vesicles and their Versatile Roles in Tissue Engineering. Tissue Engineering. Part A |
| Schardt JS, Oubaid JM, Williams SC, et al. (2017) Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells. Molecular Pharmaceutics |